BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38682349)

  • 1. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
    Zhang L; Yang L; Du K
    J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression.
    Guo Y; Chen T; Liang X; Gou S; Xiong J; Cui J; Peng T
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth.
    Wang N; Yu Y; Wang R; Chen Y; Tang J
    Comput Math Methods Med; 2022; 2022():8509626. PubMed ID: 36035281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS.
    Chen L; Zhang J; Chen Q; Ge W; Meng L; Huang X; Shen P; Yuan H; Shi G; Miao Y; Jiang K
    Int J Cancer; 2020 Jul; 147(1):175-188. PubMed ID: 31837005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer.
    Liang Y; Wang Y; Zhang Y; Ye F; Luo D; Li Y; Jin Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Ma T; Kong X; Yang Q
    Cell Death Dis; 2023 Jul; 14(7):434. PubMed ID: 37454220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cell-derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2-related factor 2 pathway and inhibiting ferroptosis.
    Chen J; Li X; Liu H; Zhong D; Yin K; Li Y; Zhu L; Xu C; Li M; Wang C
    Diabet Med; 2023 Jul; 40(7):e15031. PubMed ID: 36537855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
    Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
    Cao W; Zeng Z; He Z; Lei S
    Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSPB1 as a novel regulator of ferroptotic cancer cell death.
    Sun X; Ou Z; Xie M; Kang R; Fan Y; Niu X; Wang H; Cao L; Tang D
    Oncogene; 2015 Nov; 34(45):5617-25. PubMed ID: 25728673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein B1 is a key mediator of prolactin-induced beta-cell cytoprotection against oxidative stress.
    Terra LF; Wailemann RAM; Dos Santos AF; Gomes VM; Silva RP; Laporte A; Meotti FC; Terra WR; Palmisano G; Lortz S; Labriola L
    Free Radic Biol Med; 2019 Apr; 134():394-405. PubMed ID: 30699366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex.
    Wang S; Chen J; Li P; Chen Y
    Cell Death Dis; 2023 Nov; 14(11):767. PubMed ID: 38007473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.
    Heinrich JC; Tuukkanen A; Schroeder M; Fahrig T; Fahrig R
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1349-61. PubMed ID: 21833720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant HSPB1 causes loss of translational repression by binding to PCBP1, an RNA binding protein with a possible role in neurodegenerative disease.
    Geuens T; De Winter V; Rajan N; Achsel T; Mateiu L; Almeida-Souza L; Asselbergh B; Bouhy D; Auer-Grumbach M; Bagni C; Timmerman V
    Acta Neuropathol Commun; 2017 Jan; 5(1):5. PubMed ID: 28077174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.
    Shang D; Xie C; Hu J; Tan J; Yuan Y; Liu Z; Yang Z
    J Cell Mol Med; 2020 Jan; 24(1):588-604. PubMed ID: 31724333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
    Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
    FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
    Wang L; Wu S; He H; Ai K; Xu R; Zhang L; Zhu X
    Lab Invest; 2022 Dec; 102(12):1323-1334. PubMed ID: 35945269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis.
    Huo Q; Wang J; Xie N
    BMC Cancer; 2023 Jun; 23(1):501. PubMed ID: 37268925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSPB1 overexpression improves hypoxic-ischemic brain damage by attenuating ferroptosis in rats through promoting G6PD expression.
    Dai Y; Hu L
    J Neurophysiol; 2022 Dec; 128(6):1507-1517. PubMed ID: 36321738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.
    Hoshi H; Sawada T; Uchida M; Saito H; Iijima H; Toda-Agetsuma M; Wada T; Yamazoe S; Tanaka H; Kimura K; Kakehashi A; Wei M; Hirakawa K; Wanibuchi H
    Int J Oncol; 2011 Mar; 38(3):619-27. PubMed ID: 21249315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.